vs
Perma-Pipe International Holdings, Inc.(PPIH)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Perma-Pipe International Holdings, Inc.的1.1倍($69.8M vs $61.1M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs 10.3%,领先373.7%),Perma-Pipe International Holdings, Inc.同比增速更快(47.1% vs 21.2%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 23.4%)
Perma-Pipe International Holdings是一家专业研发、生产、销售预绝缘管道系统及一体化泄漏检测解决方案的企业,产品覆盖油气、区域冷暖、工业、市政基建等领域,业务遍布北美、中东、欧洲、亚洲等全球市场。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
PPIH vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$61.1M
营收增速更快
PPIH
高出25.9%
21.2%
净利率更高
RIGL
高出373.7%
10.3%
两年增速更快
RIGL
近两年复合增速
23.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $61.1M | $69.8M |
| 净利润 | $6.3M | $268.1M |
| 毛利率 | 34.4% | 91.5% |
| 营业利润率 | 18.6% | 33.2% |
| 净利率 | 10.3% | 384.0% |
| 营收同比 | 47.1% | 21.2% |
| 净利润同比 | 153.5% | 1769.2% |
| 每股收益(稀释后) | $0.77 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PPIH
RIGL
| Q4 25 | $61.1M | $69.8M | ||
| Q3 25 | $47.9M | $69.5M | ||
| Q2 25 | $46.7M | $101.7M | ||
| Q1 25 | $45.0M | $53.3M | ||
| Q4 24 | $41.6M | $57.6M | ||
| Q3 24 | $37.5M | $55.3M | ||
| Q2 24 | $34.3M | $36.8M | ||
| Q1 24 | $40.2M | $29.5M |
净利润
PPIH
RIGL
| Q4 25 | $6.3M | $268.1M | ||
| Q3 25 | $851.0K | $27.9M | ||
| Q2 25 | $5.0M | $59.6M | ||
| Q1 25 | $1.8M | $11.4M | ||
| Q4 24 | $2.5M | $14.3M | ||
| Q3 24 | $3.3M | $12.4M | ||
| Q2 24 | $1.4M | $-1.0M | ||
| Q1 24 | $8.6M | $-8.2M |
毛利率
PPIH
RIGL
| Q4 25 | 34.4% | 91.5% | ||
| Q3 25 | 30.1% | 93.2% | ||
| Q2 25 | 35.8% | 95.6% | ||
| Q1 25 | 33.7% | 91.7% | ||
| Q4 24 | 33.9% | 89.9% | ||
| Q3 24 | 35.9% | 85.5% | ||
| Q2 24 | 30.6% | 92.4% | ||
| Q1 24 | 30.0% | 93.1% |
营业利润率
PPIH
RIGL
| Q4 25 | 18.6% | 33.2% | ||
| Q3 25 | 6.7% | 40.9% | ||
| Q2 25 | 16.9% | 60.1% | ||
| Q1 25 | 12.1% | 23.9% | ||
| Q4 24 | 13.4% | 28.9% | ||
| Q3 24 | 16.4% | 25.4% | ||
| Q2 24 | 9.1% | 1.2% | ||
| Q1 24 | 11.3% | -23.6% |
净利率
PPIH
RIGL
| Q4 25 | 10.3% | 384.0% | ||
| Q3 25 | 1.8% | 40.2% | ||
| Q2 25 | 10.6% | 58.6% | ||
| Q1 25 | 3.9% | 21.5% | ||
| Q4 24 | 6.0% | 24.9% | ||
| Q3 24 | 8.8% | 22.5% | ||
| Q2 24 | 4.2% | -2.8% | ||
| Q1 24 | 21.5% | -27.9% |
每股收益(稀释后)
PPIH
RIGL
| Q4 25 | $0.77 | $14.11 | ||
| Q3 25 | $0.10 | $1.46 | ||
| Q2 25 | $0.61 | $3.28 | ||
| Q1 25 | $0.23 | $0.63 | ||
| Q4 24 | $0.31 | $0.82 | ||
| Q3 24 | $0.40 | $0.70 | ||
| Q2 24 | $0.18 | $-0.06 | ||
| Q1 24 | $1.07 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $27.2M | $155.0M |
| 总债务越低越好 | $12.7M | $52.5M |
| 股东权益账面价值 | $85.8M | $391.5M |
| 总资产 | $217.0M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.15× | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
PPIH
RIGL
| Q4 25 | $27.2M | $155.0M | ||
| Q3 25 | $17.3M | $137.1M | ||
| Q2 25 | $18.8M | $108.4M | ||
| Q1 25 | $15.7M | $77.1M | ||
| Q4 24 | $13.3M | $77.3M | ||
| Q3 24 | $9.5M | $61.1M | ||
| Q2 24 | $7.7M | $49.1M | ||
| Q1 24 | $5.8M | $49.5M |
总债务
PPIH
RIGL
| Q4 25 | $12.7M | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | $15.2M | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | $15.2M | $60.0M |
股东权益
PPIH
RIGL
| Q4 25 | $85.8M | $391.5M | ||
| Q3 25 | $80.2M | $117.6M | ||
| Q2 25 | $77.9M | $81.9M | ||
| Q1 25 | $72.1M | $18.6M | ||
| Q4 24 | $71.2M | $3.3M | ||
| Q3 24 | $68.6M | $-14.6M | ||
| Q2 24 | $65.5M | $-29.9M | ||
| Q1 24 | $65.7M | $-31.7M |
总资产
PPIH
RIGL
| Q4 25 | $217.0M | $513.6M | ||
| Q3 25 | $189.0M | $242.5M | ||
| Q2 25 | $178.3M | $206.7M | ||
| Q1 25 | $165.2M | $176.0M | ||
| Q4 24 | $160.7M | $164.0M | ||
| Q3 24 | $157.8M | $139.4M | ||
| Q2 24 | $155.7M | $128.4M | ||
| Q1 24 | $155.7M | $126.5M |
负债/权益比
PPIH
RIGL
| Q4 25 | 0.15× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | 0.21× | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $17.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $12.4M | — |
| 自由现金流率自由现金流/营收 | 20.2% | — |
| 资本支出强度资本支出/营收 | 8.1% | — |
| 现金转化率经营现金流/净利润 | 2.74× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $12.3M | — |
8季度趋势,按日历期对齐
经营现金流
PPIH
RIGL
| Q4 25 | $17.3M | $22.0M | ||
| Q3 25 | $-2.0M | $24.0M | ||
| Q2 25 | $733.0K | $30.5M | ||
| Q1 25 | $6.0M | $-893.0K | ||
| Q4 24 | $5.2M | $14.5M | ||
| Q3 24 | $2.8M | $21.7M | ||
| Q2 24 | $-73.0K | $302.0K | ||
| Q1 24 | $7.1M | $-5.0M |
自由现金流
PPIH
RIGL
| Q4 25 | $12.4M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-194.0K | — | ||
| Q1 25 | $4.7M | — | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $-662.0K | — | ||
| Q1 24 | $4.2M | — |
自由现金流率
PPIH
RIGL
| Q4 25 | 20.2% | — | ||
| Q3 25 | -9.6% | — | ||
| Q2 25 | -0.4% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 11.6% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | -1.9% | — | ||
| Q1 24 | 10.5% | — |
资本支出强度
PPIH
RIGL
| Q4 25 | 8.1% | — | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 7.2% | — |
现金转化率
PPIH
RIGL
| Q4 25 | 2.74× | 0.08× | ||
| Q3 25 | -2.40× | 0.86× | ||
| Q2 25 | 0.15× | 0.51× | ||
| Q1 25 | 3.42× | -0.08× | ||
| Q4 24 | 2.07× | 1.01× | ||
| Q3 24 | 0.86× | 1.75× | ||
| Q2 24 | -0.05× | — | ||
| Q1 24 | 0.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图